Temozolomide: A Safe and Effective Treatment for Malignant Digestive Endocrine TumorsMAIRE, Frédérique; HAMMEL, Pascal; RUSZNIEWSKI, Philippe et al.Neuroendocrinology (Basel). 2009, Vol 90, Num 1, pp 67-72, issn 0028-3835, 6 p.Article

Cooperative function of Chk1 and p38 pathways in activating G₂ arrest following exposure to temozolomideHIROSE, Yuichi; KATAYAMA, Makoto; BERGER, Mitchel S et al.Journal of neurosurgery. 2004, Vol 100, Num 6, pp 1060-1065, issn 0022-3085, 6 p.Article

Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosisFRANCESCHI, Enrico; CAVALLO, Giovanna; SCOPECE, Luciano et al.Journal of neuro-oncology. 2005, Vol 73, Num 3, pp 261-264, issn 0167-594X, 4 p.Article

Temozolomide in the treatment of solid tumours: current results and rationale for dosing/schedulingPAYNE, M. J; PRATAP, S. E; MIDDLETON, M. R et al.Critical reviews in oncology/hematology. 2005, Vol 53, Num 3, pp 241-252, issn 1040-8428, 12 p.Article

A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMTBROWN, Chad C; HAVENER, Tammy M; MEDINA, Marisa W et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 11, pp 796-802, issn 1744-6872, 7 p.Article

INHIBITION OF METALLOPROTEINASES DERIVED FROM TUMOURS: NEW INSIGHTS IN THE TREATMENT OF HUMAN GLIOBLASTOMAGABELLONI, P; DA POZZO, E; BENDINELLI, S et al.Neuroscience. 2010, Vol 168, Num 2, pp 514-522, issn 0306-4522, 9 p.Article

MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in GliomaLI, Rui-Yan; CHEN, Ling-Chao; YANG, Dong-Bo et al.CNS neuroscience & therapeutics (Print). 2013, Vol 19, Num 7, pp 477-483, issn 1755-5930, 7 p.Article

In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent TemozolomideWHOON JONG KIL; CERNA, David; BURGAN, William E et al.Clinical cancer research. 2008, Vol 14, Num 3, pp 931-938, issn 1078-0432, 8 p.Article

Chemotherapy-Associated Steatohepatitis with Temozolomide and DexamethasoneMILLER, Robert J. H; XIANYONG GUI; EASAW, Jacob C et al.Canadian journal of neurological sciences. 2012, Vol 39, Num 4, pp 547-549, issn 0317-1671, 3 p.Article

Treatment of Nelson's syndrome with temozolomideMOYES, V. J; ALUSI, G; SABIN, H. I et al.European journal of endocrinology. 2009, Vol 160, Num 1, pp 115-119, issn 0804-4643, 5 p.Article

Chemotherapy as initial treatment in gliomatosis cerebri: Results with temozolomideLEVIN, Netta; GOMORI, John Moshe; SIEGAL, Tali et al.Neurology. 2004, Vol 63, Num 2, pp 354-356, issn 0028-3878, 3 p.Article

Evaluation of the exposure equivalence of oral versus intravenous temozolomideDIEZ, Blanca D; STATKEVICH, Paul; OTTAVIANO, Fabio H et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 4, pp 727-734, issn 0344-5704, 8 p.Article

Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumoursBARUCHEL, S; DIEZI, M; HARGRAUE, D et al.European journal of cancer (1990). 2006, Vol 42, Num 14, pp 2335-2342, issn 0959-8049, 8 p.Article

A mechanistic mathematical model of temozolomide myelosuppression in children with high-grade gliomasPANETTA, John Carl; KIRSTEIN, Mark N; GAJJAR, A. J et al.Mathematical biosciences. 2003, Vol 186, Num 1, pp 29-41, issn 0025-5564, 13 p.Article

Population-based survival analyses of central nervous system tumors from 1994 to 2008. An up-dated study in the temozolomide-eraFUENTES-RASPALL, Rafael; PUIG-VIVES, Montserrat; GUERRA-PRIO, Silvia et al.Cancer epidemiology (Print). 2014, Vol 38, Num 3, pp 244-247, issn 1877-7821, 4 p.Article

Strategies to Improve the Killing of Tumors Using Temozolomide: Targeting the DNA Repair Protein MGMT : Cancer Chemoresistance and DNA RepairJIANG, G; LI, L.-T; XIN, Y et al.Current medicinal chemistry. 2012, Vol 19, Num 23, pp 3886-3892, issn 0929-8673, 7 p.Article

Hypersensitivity pneumonitis associated with the use of temozolomideKOSCHEL, D; HANDZHIEV, S; LEUCHT, V et al.The European respiratory journal. 2009, Vol 33, Num 4, pp 931-934, issn 0903-1936, 4 p.Article

Rechallenge with temozolomide in patients with recurrent gliomasWICK, Antje; PASCHER, Christina; WICK, Wolfgang et al.Journal of neurology. 2009, Vol 256, Num 5, pp 734-741, issn 0340-5354, 8 p.Article

Temozolomide in combination with fotemustine in patients with metastatic melanomaTAS, Faruk; CAMLICA, Hakan; TOPUZ, Erkan et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 2, pp 293-298, issn 0344-5704, 6 p.Article

Temozolomide-Induced Desquamative Skin Rash in a Patient with Metastatic MelanomaPICK, Amy M; NEFF, William J; NYSTROM, Kelly K et al.Pharmacotherapy. 2008, Vol 28, Num 3, pp 406-409, issn 0277-0008, 4 p.Article

Novel role of triazenes in haematological malignancies : Pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemiaCAPORASO, Patrizia; TURRIZIANI, Mario; BONMASSAR, Enzo et al.DNA repair. 2007, Vol 6, Num 8, pp 1179-1186, issn 1568-7864, 8 p.Article

Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas : a clinical efficacy trialTALIANSKV-ARONOV, A; BOKSTEIN, F; LAVON, I et al.Journal of neuro-oncology. 2006, Vol 79, Num 2, pp 153-157, issn 0167-594X, 5 p.Article

Temozolomide with or without radiotherapy in melanoma with unresectable brain metastasesHOFMANN, Maja; KIECKER, Felix; WURM, Reinhard et al.Journal of neuro-oncology. 2006, Vol 76, Num 1, pp 59-64, issn 0167-594X, 6 p.Article

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II StudyCHRISTODOULOU, Christos; BAFALOUKOS, Dimitrios; LINARDOU, Helen et al.Journal of neuro-oncology. 2005, Vol 71, Num 1, pp 61-65, issn 0167-594X, 5 p.Article

Temozolomide and cisplatin in avdanced malignant melanomaDAPONTE, Antonio; ASCIERTO, Paolo Antonio; GRAVINA, Adriano et al.Anticancer research. 2005, Vol 25, Num 2B, pp 1441-1447, issn 0250-7005, 7 p.Article